Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status
AUTOR(ES)
Tubbs, Raymond
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2734394Documentos Relacionados
- Chemotherapy for early-stage breast cancer: a brief history
- Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review
- Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.
- Referral, Receipt, and Completion of Chemotherapy in Patients With Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer Recurrence
- Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review.